Arcturus Therapeutics Holdings (ARCT) Profit After Tax (2018 - 2026)

Arcturus Therapeutics Holdings (ARCT) has 9 years of Profit After Tax data on file, last reported at -$27.0 million in Q1 2026.

• Quarterly Profit After Tax fell 91.56% year-over-year to -$27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$78.7 million (down 15.35% YoY) and the FY2025 annual result came in at -$65.8 million, up 18.73% from the prior year.
• Profit After Tax rose to -$27.0 million in Q1 2026, from -$29.1 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $117.3 million in Q4 2022 to a low of -$52.6 million in Q2 2023.
• A 5-year average of -$11.4 million and a median of -$17.2 million in 2024 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax soared 403.51% — and 2024, when it tumbled 156.3%.
• Tracing ARCT's Profit After Tax over 5 years: stood at $117.3 million in 2022, then tumbled by 109.98% to -$11.7 million in 2023, then sank by 156.3% to -$30.0 million in 2024, then rose by 3.09% to -$29.1 million in 2025, then gained by 7.27% to -$27.0 million in 2026.
• The last three Profit After Tax figures came in at -$27.0 million (Q1 2026), -$29.1 million (Q4 2025), and -$13.4 million (Q3 2025), per Business Quant data.